Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

New Definitive Healthcare Surveys Reveal COVID-19 Trends and Predictions


News Image

“Both of our COVID-19 research studies point to a few overlapping concerns: risks of closure due to financial implications, an uptick in non-essential staff layoffs, PPE shortages, clinical staffing shortages, and resource distribution concerns,” said Kate Shamsuddin, CPO of Definitive Healthcare.

Definitive Healthcare, the leading provider of data, intelligence, and analytics on the healthcare provider market, today released results from its 2020 COVID-19 Acute Care Research Study, and its 2020 COVID-19 Physician Practices Research Study. Healthcare leaders from 81 different organizations participated in the study, spanning 34 different states – to understand how the COVID-19 pandemic has impacted the (1) acute hospital environment and (2) physician practices.

For the two COVID-19 studies, Definitive Healthcare surveyed 161 healthcare leaders across the United States – uncovering the ways acute care organizations and physician practices prepared and adapted, along with what might be on the horizon as they work to accommodate a variety of challenges in this uncertain time. The collected insight shows highlights of the two studies’ findings:

Acute Care Organizations Survey: Impact of COVID-19

  • COVID-19 Testing: 83% of organizations are utilizing multiple COVID-19 screening methods.
  • Capacity Concerns: 43% of organizations predict they will reach bed capacity at some point in 2020.
  • Risk of Closure: 40% of organizations are at risk of closure due to financial implications of COVID-19, where organizations with less than 100 beds are impacted the greatest
  • Personal Protective Equipment (PPE) Shortage: 72% of organizations have obtained PPE from means outside of their normal supply chain methods.
  • Staffing Shortages & Layoffs: 30% of organizations predict clinical staffing shortages due to exposure to COVID-19. At-risk organizations have laid off non-essential staff at over two times the rate of those not at risk (22% vs. 10%).

Physician Practices Survey: Impact of COVID-19

  • Telehealth Implementation: 95% of respondents have implemented a telehealth solution as result of the COVID-19 pandemic
  • Capacity Concerns: 89% of organizations have yet to see their peak case rate.
  • Personal Protective Equipment (PPE) Shortage: 82% of physician practices have sourced or requested PPE from means outside of their normal supply chain method.
  • Risk of Closure: 36% of organizations are at risk of closure due to the financial implications of COVID-19, 69% of which are organizations consisting of less than 10 physicians.
  • Staffing Shortages & Layoffs: 25% of organizations predict clinical staffing shortages due to exposure to COVID-19. At-risk organizations have laid off non-essential staff at over three times the rate of those not at risk (38% v. 10%). 42% of affiliated practices have re-purposed their staff, sending them to the hospital to support COVID-19 response to patient care.

“Both of our COVID-19 research studies point to a few overlapping concerns: risks of closure due to financial implications – particularly in smaller organizations, an uptick in non-essential staff layoffs, PPE shortages, clinical staffing shortages due to COVID-19 exposure, and resource distribution concerns,” said Kate Shamsuddin, Chief Product Officer of Definitive Healthcare. “During this difficult time, Definitive Healthcare has created two maps to track and predict time-sensitive COVID-19 resource distribution and re-opening metrics. Our COVID-19 Capacity Predictor assists in predicting where, and when, important resources should be allocated as case volume continues to grow, and our COVID-19 Re-Opening Analysis Predictor captures key metrics that indicate when different states and counties can begin safely easing stay-at-home restrictions. We will continue to release Predictor series maps to give government officials, healthcare organizations, and the public free, predictive lenses to understand the crisis and plan accordingly.”

Please view the surveys in greater detail here.

Share article on social media or email:

Mothers Against Drunk Driving Urges Safety During Upcoming July 4th Holiday


News Image

A long holiday weekend can bring more traffic and more risk on our roads, especially this year, when so many of us have refrained from traveling for months. We want everyone to enjoy the holiday, just remember to designate a non-drinking driver every time plans include alcohol.

Long holiday weekends can be dangerous on America’s roads, and July 4th and the days surrounding the national holiday are among the deadliest for drunk driving. Mothers Against Drunk Driving (MADD) urges everyone to celebrate safely by planning ahead and designating a non-drinking driver if plans include alcohol.

More people die in drunk driving crashes in July than any other month, according to the National Highway Traffic Safety Administration (NHTSA). The July 4th holiday is particularly deadly. In 2018, 193 people died in motor vehicle traffic crashes over the July 4th holiday period (6 p.m. July 3 to 5:59 a.m. July 5). Forty percent (78) of those fatalities occurred in alcohol-impaired-driving crashes. This compares to 2017 when 38% of the July 4 holiday period fatalities occurred in alcohol-impaired-driving crashes. From 2014 to 2018, 812 people were killed in drunk-driving crashes over those 36-hours.

“As we celebrate Independence Day, we want to make sure we keep ourselves and our families safe,” said MADD National President Helen Witty. “A long holiday weekend can bring more traffic and more risk on our roads, especially this year, when so many of us have refrained from traveling for months. We want everyone to enjoy the holiday, just remember to designate a non-drinking driver every time plans include alcohol.”

According to NHTSA, nighttime hours are especially dangerous. Over the 2018 July 4th holiday period, of the 78 people who died in alcohol-impaired motor vehicle traffic crashes, all but 9 of them occurred at night (6 p.m.–5:59 a.m.).

Drunk driving is the leading killer on America’s roads, accounting for one-third of all traffic deaths and claiming the lives of more than 10,000 people every year.

Someone dies in a drunk driving crash every 50 minutes in the U.S., yet these senseless deaths are 100 percent preventable, 100 percent of the time. MADD’s Campaign to Eliminate Drunk Driving is helping create a future with No More Victims®. The campaign includes advocacy for stronger drunk driving laws including ignition interlocks for all drunk driving offenders, support for high-visibility law enforcement, support for advanced drunk driving prevention technology in all cars and public support for these initiatives.

MADD reminds everyone to take personal responsibility every day by using taxis, public transportation, rideshare services or calling a non-drinking friend if their plans include alcohol.

About Mothers Against Drunk Driving

Founded in 1980 by a mother whose daughter was killed by a drunk driver, Mothers Against Drunk Driving® (MADD) is the nation’s largest nonprofit working to end drunk driving, help fight drugged driving, support the victims of these violent crimes and prevent underage drinking. MADD has helped to save more than 390,000 lives, reduce drunk driving deaths by more than 50 percent and promote designating a non-drinking driver. MADD’s Campaign to Eliminate Drunk Driving® calls for law enforcement support, ignition interlocks for all offenders and advanced vehicle technology. MADD has provided supportive services to nearly one million drunk and drugged driving victims and survivors at no charge through local victim advocates and the 24-Hour Victim Help Line 1-877-MADD-HELP. Visit http://www.madd.org or call 1-877-ASK-MADD.

Share article on social media or email:

Comanche Nation Entertainment Installs eConnect’s eClear Solution for COVID-19 Elevated Temperature Screening


News Image

Our mission is to make Comanche Nation casinos safe places for our guests, team members, and tribal members, Mia Tahdooahnippah, CEO of Comanche Nation Entertainment

As the country begins to re-open, operators like Comanche Nation Entertainment are doing everything they can to make their team members and guest feel safe from Covid-19. Checking for elevated temperatures is critical as it may help mitigate the spread of the virus. Studies have shown that elevated temperature is prevalent in 87.9% of people who present symptoms; it is the number one thing to look for when allowing people into a building.

“Our mission is to make Comanche Nation casinos safe places for our guests, team members, and tribal members,” said Mia Tahdooahnippah, CEO of Comanche Nation Entertainment. “Our management team ultimately decided to use eConnect’s eClear thermal temperature scanner, which scans the temperatures of guests in a quick, contactless process when they enter the casino. This helps ensure the safety of our guests and team members and allows people to scan themselves in accordance with social distancing guidelines set forth by the CDC.”

eClear is lightweight and portable, can be placed at guest or team member entrances and can be permanently mounted if desired. Due to its effectiveness as well as its ease of use, eClear is gaining wide adoption.

“We have been working with thermogenic sensors for 5 years and when COVID-19 hit, we were ready to help our business partners with a solution,” said, Chris Swanger, RVP of Sales in Oklahoma. “We have adopted the best practices and standards being set forth throughout businesses across the country, and we are happy to help Comanche Nation casinos deploy the safest and most effective solution to reopen their properties and keep them open long-term. We feel so fortunate to have a customer like them. The team at Comanche Nation Casinos is such a pleasure to work with and their genuine hospitality sets a great example for the gaming community.”

In addition to the basics of preventing the spread of disease by automatically checking temperatures, the facial matching component offers many benefits, such as a real-time aggregate count of all entrances and exits while simultaneously recognizing and alerting about valuable customers. The system can also alert the team about the arrival of banned customers even if they are wearing face masks. When placed at team member entrances, eClear can be used as a hands-free time clock to keep team members safe.

About Comanche Nation Entertainment

Comanche Nation Entertainment supports the Comanche Nation tribe’s approximately 17,000 members in Oklahoma. The company’s five Oklahoma casinos include Comanche Nation Casino, Comanche Red River Hotel Casino, Comanche Spur Casino, Comanche Star Casino and the Comanche Nation Travel Plaza. For more information, visit http://www.comanchenationentertainment.com.

About eConnect

eConnect™ is a cutting-edge technology company that helps improve business performance through data and video intelligence. The company seamlessly integrates digital video surveillance analytics, including facial recognition, with transactional data from point-of-sale (POS), casino systems and other data sources to improve profitability quickly and directly, efficiency and the guest experience. eConnect offers measurable ROI within months of system deployment. The tools are world-renowned for their ability to discover previously unknown problems, thereby reducing eliminating sources of loss and correcting operational problems. In response to Covid-19, eConnect has expanded its solutions to enable customers to reopen safely and efficiently. For more information, visit http://www.econnectglobal.com.

Share article on social media or email:

EvidenceCare Announces Launch of Admission Criteria Solution Driving Real ROI through Clinical Decision Support Technology


Carol Howard

EvidenceCare, a leading provider of advanced clinical decision support (CDS) technology, today announced the launch of its innovative Admission Criteria solution expanding the company’s CDS platform to create real impact on the hospital revenue cycle by ensuring accurate admission documentation to proactively address a significant source of denials. The company is also announcing the addition of Carol Howard as vice president of clinical content, an industry expert on the clinical aspects of the revenue cycle.

The Admission Criteria solution, developed in partnership with MCG Health, enables a clinically driven revenue cycle by incorporating evidence-based admission criteria to properly determine and document bed status at the time of admission. The solution offers significant financial return for hospitals based on inappropriate bed status, determinations, and denials due to insufficient documentation.

To support both content and business development efforts, Carol Howard offers a unique blend of clinical and revenue cycle experience to add to the EvidenceCare team. As a registered nurse with extensive background in decision support, denials, utilization and revenue management, she will leverage her deep knowledge base to lead the ongoing development and support of the Admission Criteria solution.

“Emergency Departments (ED) are the front door of the hospital. They face the daunting challenge of making split-second decisions and deserve immediate access to updated medical research to ensure the best clinical outcome for patients,” said Dr. Brian Fengler, chief executive officer and co-founder of EvidenceCare. “We are thrilled to have Carol join the team and apply her front-line nursing experience and revenue cycle expertise to the launch of the Admission Criteria solution. With Carol’s leadership, we will enable frontline providers to deliver effective, efficient, and evidenced-based care.”

“Clinicians drive the revenue cycle through accurate documentation. Too often, we address denials after the fact when a proactive approach could address up to 60% of denials,” said Carol Howard, vice president, clinical content of EvidenceCare. “I am looking forward to becoming an integral part of the forward-thinkers at EvidenceCare that seek creative solutions to help hospitals remain solvent, especially given the impact of the pandemic, so that they might continue to deliver excellent care in the communities they serve.”

About EvidenceCare

EvidenceCare is the leading clinical decision support system (CDSS) driving real ROI. Founded in response to the professional experience of emergency physician Dr. Brian Fengler, the platform is integrated into a clinician’s EHR workflow, delivering customized, interactive, curated guidance directly into the care process. With EvidenceCare, hospitals, emergency departments and urgent care centers enable clinicians to deliver evidence-based care with measurable outcomes. Through advanced CDSS technology, variance is reduced, and the appropriate criteria are documented during utilization and admission decisions. With government-mandated compliance measures and quality program initiatives achieved, healthcare organizations ensure that quality and safety improve, liability is reduced, and operational efficiency is increased while capturing additional revenue. To learn more, visit http://www.evidence.care or follow us on Twitter @evidencecare or LinkedIn.

About MCG Health

MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move people toward health. MCG’s transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers, and payers the vetted information they need to feel confident in every care decision, in every moment. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.

Share article on social media or email:



Luminec Pharmaceuticals Submits New Evidence for NIH, BARDA Coronavirus Application


Dr. Susana Alcázar-Leyva

Based on these new studies, we believe that X-2 and CRO-50 can make a significant contribution in the treatment of the novel Coronavirus.

As part of its application for consideration to the National Institute of Allergies and Infectious Diseases (NIAID) and to the Biomedical Advanced Research and Development Authority (BARDA), Luminec Pharmaceuticals is submitting new case studies showing strong evidence of the efficacy of our combined therapy of CRO-50 (ribonuclease) and X-2 (stable thiamine formulation) in COVID-19 patients, as well as in other Coronavirus patients.

These case studies were compiled by Luminec Executive Board Member Susana Alcázar-Leyva, MD, PhD, based on her first-hand experience with patients around the world. According to Dr. Alcázar-Leyva, “Based on these new studies, we believe that X-2 and CRO-50 can make a significant contribution in the treatment of the novel Coronavirus.”

In addition to her role with Luminec Pharmaceuticals, Dr. Alcázar-Leyva is a founding director of the prestigious Hans Selye Scientific Research Institute, and cofounder and director of the Heberto Alcázar-Montenegro Gerontology School (cofounded by, and named for, her father), and of the Albert Szent-Györgyi Gerontology Center.

Stephen Holt, MD, DSc, PhD, Luminec chief science officer, commented, “We are presenting Dr. Alcázar-Leyva’s findings to BARDA and NIAID to support our application in the hopes that our protocols will be cleared for a regulatory pathway to FDA approval.” Dr. Holt noted that Luminec Pharmaceuticals is also making a similar submission to the Israel National Institute for Health Policy Research (NIHP) for consideration in their battle with the Coronavirus.

About Luminec Pharmaceuticals

Headquartered in Carlsbad, CA, Luminec Pharmaceuticals currently offers a unique array of all-natural OTC products and clinical services for both human and animal use. Luminec’s products include natural proprietary formulations based on the Schutt Paradigm of Free Amino Ion Alignment & Molecular Stability, in combination with proprietary partner technologies with a cutting edge delivery technology, oral and topically, composed of charged delivery spheres that encapsulate and transport active compounds into the system, naturally.

Luminec Pharmaceuticals is a wholly owned subsidiary of Luminec Holding Corporation, a private company.

Share article on social media or email:

Flagship Biosciences Launches New Clinical Diagnostics Service


Flagship Biosciences, Inc. Logo

Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists in optimizing care for cancer patients.

Flagship Biosciences, providers of expert tissue data insights, today announced that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight. TissueInsight provides CLIA-reportable PD-L1 results along with data about the tumor microenvironment (TME).

“Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists in optimizing care for cancer patients,” said Trevor Johnson, Flagship CEO. “It provides immediate image analysis results without the need for an upfront monetary investment, internal development time or validation. TissueInsight reports can also be customized using additional biomarkers and image analysis.”

Flagship’s exclusive, targeted testing in its College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified lab delivers the highly accurate tissue scoring needed for precision medicine. Combined with its award-winning technology and sign-off from its experienced pathologists for every client, TissueInsight gives rapid, data-rich tissue interpretations and removes the inherent variability of subjective manual tissue scoring. Along with its CLIA-reportable results, TissueInsight TME data includes information on tumor infiltrating lymphocytes (TILs) and macrophages.

“I’m extremely pleased to bring this new clinical diagnostics service to the market,” said Johnson. “Flagship’s scientific process, machine learning, and laboratory capabilities are enabling us to work with clinicians to expand immuno-oncology diagnostic tissue tests that will make their work more efficient and better help them to deliver on the promise of precision medicine for their patients.”

About Flagship Biosciences

Founded in 2009 and headquartered in Westminster, Colorado, Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the most accurate and informative data available. It is revolutionizing tissue analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Flagship’s services and technology dramatically improve on the data and interpretation from traditional pathology methods, eliminating variability and bringing new insights to tissue analysis results. With expert scientific consultation for every client, Flagship’s team interprets results, contextualizes tissue biology, and identifies the best course for success. flagshipbio.com

For more information please contact Pamela Curran of Stratos Global Marketing, at pam@stratosglobalmarketing.com or +1 (303) 818 9316.

Share article on social media or email:

State Veterinary Medical Associations Endorse FELINE FIX BY FIVE MONTHS as best practice


News Image

STATE VETERINARY MEDICAL ASSOCIATIONS ENDORSE FELINE FIX BY FIVE MONTHS AS BEST PRACTICE

Following the lead of the American Veterinary Medical Association, the American Animal Hospital Association, and the American Association of Feline Practitioners, state veterinary medical associations in Maine, Arkansas, Kentucky and Mississippi have formally endorsed the best practice of spaying or neutering cats before five months of age.

“When state veterinary associations embrace and endorse the recommended best practice of spaying and neutering cats by five months of age, it amplifies our message that the benefits of ‘fixing by five months’ are numerous and impactful to the health and welfare of cats, and to the problem of overpopulation in communities across the country and around the world,” said Feline Fix by Five’s Program Director, Esther Mechler.

Historically, the recommended age for spaying and neutering cats was six months. However, the benefits of performing surgery earlier not only result in faster recovery and fewer unwanted litters, but also health and behavioral benefits that can help reduce the number of cats relinquished to shelters by their owners.

  • The risk for mammary cancer (which is fatal in over 85% of diagnosed cases) in female cats who are spayed before their first estrous cycle is reduced by 91%.*
  • Neutering male cats reduces many undesirable behaviors such as urine marking, aggressive behavior and roaming behaviors which can result in serious injuries, diseases and death.
  • Cats sterilized before puberty are less likely to exhibit undesirable behaviors secondary to sex hormones. This also makes it more likely for cats to remain with their owners long term since many cats are surrendered to shelters due to these undesirable behaviors.

“Cat owners who may be unsure of when to spay or neuter their pet, or who wait until they are six months of age, are often faced with the dilemma of what to do with an unexpected litter of kittens. Ironically, the problem is not always the result of owners refusing to spay or neuter their cat – they simply did not know that performing the surgery before a cat reaches sexual maturity has benefits beyond just preventing ‘surprise’ litters,” said Dr. Philip Bushby, DVM, MS, DACVS, veterinary medical advisor to the Fix by Five Months campaign.

Since the Feline Fix by Five Months campaign was launched in 2016, the boards of all major national veterinary organizations and many national cat-welfare organizations have formally endorsed the practice of Fixing by Five Months.

About Feline Fix by Five Months

Feline Fix by Five Months is an initiative of Marian’s Dream, a non-profit organization that provides support to animal welfare groups and organizations dedicated to bringing awareness to animal welfare issues. The campaign’s mission is to educate veterinarians, the general public and cat owners on the medical, behavioral and community benefits of spaying and neutering cats before the age of five months. For more information, visit http://www.FixByFive.org

*”Mammary Tumors” Cornell Feline Health Center. Accessed June 2020.

FOR INFORMATION

Becky Price

860-706-2667

ctyankeeinmidwest@gmail.com

Share article on social media or email:

The HeroZona Foundation Launches Free COVID-19 Drive-Thru Testing


With Arizona seeing one of the highest COVID-19 surges in the country at 74,000 confirmed cases, continued testing remains critical. In an effort to help slow the spread of the disease, the HeroZona Foundation has partnered with SRP, the Travis L. Williams American Legion Post 65, Maricopa County’s District 5 and the Arizona Chamber of Commerce and Industry to offer free drive-thru COVID-19 testing at South Mountain Community College (7050 S. 24th St.) in Phoenix on Thursday, July 2; Friday, July 3; Thursday, July 9 and Friday, July 10 from 8 a.m. to 6 p.m.

“This effort is critically important to help provide testing for Arizonans in the South Phoenix communities,” said President & CEO of the Arizona Chamber of Commerce and Industry, Glenn Hamer. “There has been a spike in cases and this additional testing is needed now. I have a deep appreciation for Alan “AP” Powell, Founder of the HeroZona Foundation, for brining the additional testing sites to our state where it’s needed the most. The Arizona Chamber of Commerce and Industry strongly support this effort.”

The testing will be conducted by Lab24, a family owned business located in South Florida that operates nationally with a focus in molecular testing. There is no pre-registration or appointment necessary to get tested at the community event and tests will be available until supplies run out. Those who wish to get tested must have a valid ID.

“Additional testing is needed immediately in South Phoenix to keep our communities safe,” said HeroZona Foundation Founder and U.S. Army Desert Storm Veteran, Alan “AP” Powell. “We created this event to help bring additional testing sites to areas that need it the most.”

Those attending do not need to have symptoms present to be tested and the test will only check for viral symptoms, not antibodies.

“We are happy to have the opportunity to help support all of our communities in an effort to contain the Coronavirus through much needed testing,” said Territory Manager for Lab24, Marsha Wood. “Our goal with Covid-19 testing is to partner with community organizations, religious organizations, and clinics that support the undeserved population.”

The event is supported by SRP, Roosevelt Elementary School District 66, Phoenix Union High School District, Arizona State Conference NAACP, Greater Phoenix Urban League, 100 Black Men Phoenix, African American Christian Clergy Coalition, Mega 104.3 and 101.1 The Beat.

“SRP appreciates the opportunity to support this important effort,” said SRP Chief Public Affairs Executive Rob Taylor. “We are at a juncture where testing for COVID-19 across all populations is critical and we are hopeful this event will help slow the spread of the virus and further protect the communities we serve.”

“I’m proud to be part of this partnership between government, public, private and non-profit groups to serve our community in getting more testing for our residents,” said Maricopa County Supervisor for District 5, Steve Gallardo. “Along with testing, we must continue to be vigilant in wearing masks in public, practicing social distancing and frequent hand washing.”

For more information about the HeroZona Foundation and all of its programs, visit herozona.org.

About HeroZona Foundation

The mission of HeroZona Foundation is to create and empower Heroes in Phoenix communities. The HeroZona Foundation’s annual HeroZona National Veteran Summit created a multi-day networking experience to improve America’s support of veteran companies through workshops, networking, entrepreneurial connections, and seminars. The summit will return to Arizona for a fourth year in November 2020. Other programs include the Bridge Forum, Phoenix Tools 4 School, Play it Forward, Honor Walk, Veterans Reach to Teach, Voting for Veterans and Play It Forward. For more information, visit herozona.org

Share article on social media or email:

Brain Iron Accumulation Linked to Cognitive Decline in Alzheimer’s Patients


We found indications of higher iron deposition in the deep gray matter and total neocortex, and regionally in temporal and occipital lobes, in Alzheimer’s disease patients compared with age-matched healthy individuals.

Researchers using MRI have found that iron accumulation in the outer layer of the brain is associated with cognitive deterioration in people with Alzheimer’s disease, according to a study published in the journal Radiology.

Alzheimer’s disease is a progressive type of dementia that impairs and eventually destroys memory and other brain functions. There is no cure, although some treatments are thought to slow the progression.

Previous research has linked abnormally high levels of iron in the brain with Alzheimer’s disease. Iron deposition correlates with amyloid beta, a protein that clumps together in the brains of people with Alzheimer’s disease to form plaques that collect between neurons and disrupt cell function. Associations have also been found between iron and neurofibrillary tangles, abnormal accumulations of a protein called tau that collect inside neurons. These tangles block the neuron’s transport system, which harms the communication between neurons.

It is known that deep gray matter structures of patients with Alzheimer’s disease contain higher brain iron concentrations. Less is known about the neocortex, the deeply grooved outer layer of the brain that is involved with language, conscious thought and other important functions. The neocortex is challenging to assess by MRI, as the anatomy of the area makes MRI prone to distortions, signal decays and artifacts.

“The best solution to minimize these artifacts would be using ultra-high-resolution scans,” said study coauthor Reinhold Schmidt, M.D., professor of neurology and chairman of the Department of Neurology at the Medical University of Graz in Graz, Austria. “However, in the clinical setting, scan time is a limiting factor, and a compromise has to be found.”

For the new study, Dr. Schmidt and colleagues developed an approach using a 3T MRI scanner that allowed the best tradeoff between resolution and scan time, along with postprocessing to correct the influence of the distortions.

They used the MRI system to investigate baseline levels of brain iron in 100 individuals with Alzheimer’s disease and 100 healthy controls. Of the 100 participants with Alzheimer’s disease, 56 had subsequent neuropsychological testing and brain MRI at a mean follow-up of 17 months.

The technique enabled the researchers to create a map of brain iron, determining iron levels in parts of the brain like the temporal lobes, or the areas of the brain lying underneath the temples, and the occipital lobes in the back of the head.

“We found indications of higher iron deposition in the deep gray matter and total neocortex, and regionally in temporal and occipital lobes, in Alzheimer’s disease patients compared with age-matched healthy individuals,” Dr. Schmidt said.

The brain iron accumulation was associated with cognitive deterioration independently of brain volume loss. Changes in iron levels over time in the temporal lobes correlated with cognitive decline in individuals with Alzheimer’s disease.

“These results are all in keeping with the view that high concentrations of iron significantly promote amyloid beta deposition and neurotoxicity in Alzheimer’s disease,” Dr. Schmidt said.

The results point to a potential role in Alzheimer’s disease treatment for drugs that reduce the iron burden in the brain. These drugs, known as chelators, can remove excess iron from the body.

“Our study provides support for the hypothesis of impaired iron homeostasis in Alzheimer’s disease and indicates that the use of iron chelators in clinical trials might be a promising treatment target,” Dr. Schmidt said. “MRI-based iron mapping could be used as a biomarker for Alzheimer’s disease prediction and as a tool to monitor treatment response in therapeutic studies.”

###

“Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease using 3-T MRI.” Collaborating with Dr. Schmidt were Anna Damulina, M.D., Lukas Pirpamer, M.Sc., Martin Soellradl, M.Sc., Maximilian Sackl, M.Sc., Christian Tinauer, M.Sc., Edith Hofer, Ph.D., Christian Enzinger, M.D., Benno Gesierich, Ph.D., Marco Duering, M.D., Stefan Ropele, Ph.D., and Christian Langkammer, Ph.D.

Radiology is edited by David A. Bluemke, M.D., Ph.D., University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/radiology)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)

For patient-friendly information on brain MRI, visit RadiologyInfo.org.

AWATfit Rocks the Fitness Industry With New Franchise Concept


In the two short years since fitness enthusiast and entrepreneur Rich Decker founded his mobile fitness concept, AWATfit (Any Where Any Time Fitness), the business has seen explosive success in its home market of Long Island, and that was before the coronavirus pandemic forced consumers to rethink how and where they exercise. Now, fitness-oriented entrepreneurs across the country have the opportunity to replicate Decker’s success for themselves with AWATfit’s new franchise model.

AWATfit may be a young company, but Decker leveraged more than 30 years of experience in the industry to build the concept, and the business’s early success reflects a deliberate strategy to disrupt a stagnant fitness marketplace and grow fast.

“I’ve done the brick-and-mortar thing, and I got sick of it,” Decker said. “The whole industry hasn’t changed in decades even though more people are working out than ever before. I saw a big opportunity there.”

AWATfit’s primary innovation is providing outdoor workouts for clients, the demand for which Decker says unites just about everyone who has ever lifted a barbell.

“Whether you’re a professional athlete or just trying to get some exercise in after work, the one thing that everyone hates about going to the gym is the environment — running in place, staring at walls, and now germs. When you exercise outdoors, your energy and mood increase automatically, but most people don’t have access to a full set of gym equipment outside.”

AWATfit offers just that, bringing a fully loaded mobile gym built out of the back of a 20-foot pickup truck directly to clients, whether that’s at their homes, the beach, a playing field or anywhere else.

And AWATfit is not a seasonal business. Decker says he’s worked with clients in as low as 12-degree weather. In fact, AWAT originally stood for All Weather, All Terrain, but Decker changed that to Any Where, Any Time to make the concept less intimidating to more novice clients. “It’s invigorating to exercise outdoors in the winter, and our clients are excited to have the opportunity,” Decker said.

On top of providing an innovative, outdoor workout experience for clients, AWATfit’s trucks also provide profound benefits for Decker and any future AWATfit owners. By eliminating the brick-and-mortar element of gym ownership, AWATfit dramatically slashes overhead and organically expands the brand’s marketing footprint. Plus, franchise owners can be up and running within a month’s time.

“I’ll be parked in a parking lot and people will take pictures of the truck,” Decker said. “It’s a billboard you can’t pay for. I’ve never had to spend millions on rent and advertising to promote this business. All I’ve got is a really cool website, a social media presence and a 20-foot truck.”

AWATfit’s trucks are poised to “blow away the brick-and-mortar gym industry,” Decker says. “My youngest client is 10 years old, and my oldest is 86. That’s a range you are not going to see at traditional gyms. We can reach a larger client base because we come to them, and because our services are fully customizable.”

Decker expects to have little trouble finding franchisees to take his business to new markets across the country. “I’m already fielding calls every day,” he said. “People want to know how they can get their own truck and start doing business.” And that’s not just in Long Island. Decker has already gotten inquiries from prospective owners as far away as Bogota, Columbia and Australia.

“This is an incredibly attractive prospect for someone in the fitness industry who wants to own their own business,” Decker said. “There are a lot of fantastic trainers out there who don’t have a lot of management experience, and we’ve essentially packaged up a business for them so they can hit the ground running without taking a million classes or going through a giant learning curve.”

Decker plans to make the most of that eager interest from prospective franchisees, aiming to onboard up to 1,000 new franchisees in markets like California, Colorado, Florida and Michigan. And because operational costs to run the business are so low, new franchisees can get started with a modest investment. After that, they’re taking ninety cents on the dollar.

As for just who Decker is looking to bring on board, he says the qualifications are simple:

“The ideal AWATfit franchisee is anybody who loves fitness and being around people,” he said. “There’s not much else to it. If you know your way around exercise equipment and you like to work with people, this is your shot at getting rich doing what you love to do.”

To learn more about franchising with AWATfit, visit https://www.awatfit.com/franchise/.

Share article on social media or email: